Clorox (NYSE:CLX) Given New $112.00 Price Target at Deutsche Bank Aktiengesellschaft

Clorox (NYSE:CLX) had its price target trimmed by Deutsche Bank Aktiengesellschaft from $114.00 to $112.00 in a report published on Wednesday,MarketScreener reports. The firm currently has a hold rating on the stock.

A number of other equities analysts also recently commented on the company. Jefferies Financial Group restated a “buy” rating and set a $152.00 target price on shares of Clorox in a report on Tuesday, November 4th. Morgan Stanley reduced their price objective on shares of Clorox from $137.00 to $125.00 and set an “equal weight” rating on the stock in a research report on Tuesday, November 4th. Bank of America dropped their target price on shares of Clorox from $135.00 to $125.00 and set a “neutral” rating for the company in a research report on Wednesday, October 8th. Rothschild & Co Redburn cut their target price on shares of Clorox from $120.00 to $115.00 and set a “neutral” rating on the stock in a research note on Wednesday, November 5th. Finally, Wells Fargo & Company increased their price target on shares of Clorox from $108.00 to $115.00 and gave the stock an “equal weight” rating in a research note on Friday, January 23rd. One research analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and four have given a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Reduce” and an average price target of $117.00.

Clorox Price Performance

CLX stock opened at $117.68 on Wednesday. The stock has a market capitalization of $14.35 billion, a price-to-earnings ratio of 19.23, a PEG ratio of 0.57 and a beta of 0.59. The firm’s 50-day moving average price is $105.39 and its two-hundred day moving average price is $113.99. The company has a current ratio of 0.76, a quick ratio of 0.50 and a debt-to-equity ratio of 18.01. Clorox has a 12-month low of $96.66 and a 12-month high of $159.04.

Clorox (NYSE:CLX) last posted its earnings results on Tuesday, February 3rd. The company reported $1.39 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.43 by ($0.04). Clorox had a return on equity of 299.67% and a net margin of 11.17%.The business had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same period in the previous year, the business earned $1.55 earnings per share. The firm’s revenue for the quarter was down .8% compared to the same quarter last year. As a group, equities analysts predict that Clorox will post 7.15 earnings per share for the current year.

Clorox Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 28th will be paid a dividend of $1.24 per share. The ex-dividend date of this dividend is Wednesday, January 28th. This represents a $4.96 annualized dividend and a yield of 4.2%. Clorox’s payout ratio is presently 77.86%.

Insider Buying and Selling at Clorox

In other Clorox news, Director Pierre R. Breber bought 4,000 shares of the stock in a transaction dated Friday, November 21st. The stock was purchased at an average cost of $104.13 per share, for a total transaction of $416,520.00. Following the completion of the acquisition, the director owned 13,000 shares of the company’s stock, valued at approximately $1,353,690. This trade represents a 44.44% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Corporate insiders own 0.63% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in CLX. Total Investment Management Inc. purchased a new stake in shares of Clorox in the second quarter worth $25,000. Center for Financial Planning Inc. bought a new position in Clorox in the 3rd quarter worth about $25,000. Vermillion & White Wealth Management Group LLC purchased a new stake in Clorox during the 3rd quarter valued at about $25,000. NewSquare Capital LLC increased its stake in Clorox by 567.6% during the 2nd quarter. NewSquare Capital LLC now owns 227 shares of the company’s stock valued at $27,000 after purchasing an additional 193 shares in the last quarter. Finally, True Wealth Design LLC increased its stake in Clorox by 1,020.0% during the 3rd quarter. True Wealth Design LLC now owns 224 shares of the company’s stock valued at $28,000 after purchasing an additional 204 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Key Headlines Impacting Clorox

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Revenue slightly beat consensus — Q2 revenue came in at about $1.67B, a small beat versus Street estimates, which helps offset some concerns about profitability. Q2 Results Press Release
• Positive Sentiment: Some analysts still see significant upside — Jefferies retains a “buy” rating with a $151 target, signaling that at least part of Wall Street believes longer-term upside remains. Jefferies PT Article
• Neutral Sentiment: Management will present at the CAGNY conference on Feb. 19 — provides an opportunity for management to address questions about margin recovery, inventory and integration progress (potentially market-moving if new color is provided). CAGNY Presentation Notice
• Neutral Sentiment: Mixed small analyst adjustments — JPMorgan nudged its target slightly higher to $117 (neutral), signaling little change in near-term consensus. JPMorgan PT Article
• Negative Sentiment: EPS missed expectations and declined year‑over‑year — adjusted EPS of $1.39 missed consensus (~$1.43) and is down from a year ago, which pressured sentiment. Reuters Earnings Coverage
• Negative Sentiment: Margin headwinds persist — management cited higher costs, ERP/integration pressures and an inventory reset that could squeeze near‑term profits; several outlets flagged margin pressure and a profit squeeze outlook for 2026. Benzinga Profit Squeeze
• Negative Sentiment: Analyst downgrades/price‑target cuts on balance — Evercore cut its PT to $115 (underperform) and Deutsche Bank trimmed its PT to $112 (hold), adding downside risk near current levels. Evercore PT Article Deutsche Bank PT Article

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.